Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens for treating autoimmune diseases
US6475483B1 · kind B1 · utility
Assignees
Inventors
Key dates
| Filing date | Nov 30, 1999 |
| Grant date | Nov 5, 2002 |
| Priority date | — |
| Expiry date | Nov 30, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/25
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for producing proliferating cultures of dendritic cell precursors is provided. Also provided is a method for producing mature dendritic cells in culture from the proliferating dendritic cell precursors. The cultures of mature dendritic cells provide an effective means of producing novel T cell dependent antigens comprised of dendritic cell modified antigens or dendritic cells pulsed with antigen, including particulates, which antigen is processed and expressed on the antigen-activated dendritic cell. The novel antigens of the invention may be used as immunogens for vaccines or for the treatment of disease. These antigens may also be used to treat autoimmune diseases such as juvenile diabetes and multiple sclerosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.